• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 21
  3. 22
  4. 23
  5. 24
  6. 25
  7. …
  • Pfizer/BioNTech vaccine efficacy on Omicron

    19 January, 2022

    More studies have looked at the efficacy of the Pfizer/BioNTech vaccine on the Omicron variant...

    COVID-19

  • DSA BreathPass - an ultra-rapid COVID-19 detection device

    Finland // 17 January, 2022

    Receives CE certification for distribution...

    COVID-19

  • Variable waning of antibodies after Comirnaty and Coronavac

    17 January, 2022

    Coronovac antibodies wane faster than Comirnaty

    COVID-19

  • COVID-19 Update – Vaccination proof required to enter public venues

    France // 17 January, 2022

    The French National Assembly has approved of a law requiring people to provide proof of vaccination in order to enter public venues...

    COVID-19

  • Fourth booster dose considered for vulnerable citizens

    Denmark // 16 January, 2022

    Officials have indicated that they are considering implementing a fourth booster....

    COVID-19

  • Vaccine Update – Fourth booster dose optional

    Hungary // 16 January, 2022

    Updates on vaccination in Hungary...

    COVID-19

  • Omicron detected in Beijing

    China // 16 January, 2022

    Beijing has reported their first locally transmitted case of Omicron...

    COVID-19

  • Healthcare workers allowed to work if asymptomatic

    Czech Republic // 16 January, 2022

    Applies to those who do not have COVID-19 symptoms and are in healthcare...

    COVID-19

  • CDC updates guidance on masks and respirators

    United States // 15 January, 2022

    Wear the most protective mask you can that fits well and that you will wear consistently...

    COVID-19

  • COVID-19 Vaccine Update – Booster doses available for at risk groups

    Oman // 15 January, 2022

    Booster vaccine doses...

    COVID-19

  • Booster vaccination open to adults

    Saint Pierre and Miquelon // 14 January, 2022

    High risk populations above age 12 also eligible…

    COVID-19

  • Booster vaccination for the general public

    British Virgin Islands // 14 January, 2022

    Open to adults and children over the age of 12…

    COVID-19

  • COVID-19 Vaccine Update - Vaccination campaign expanded; booster dose duration shortened

    Cyprus // 14 January, 2022

    Vaccination open to all 5 years and above; waiting time for booster dose shortened to...

    COVID-19

  • Molnupiravir granted EUA

    Indonesia // 14 January, 2022

    Molnupiravir granted EUA

    COVID-19

  • WHO recommends new drugs for severe and non-severe COVID-19

    14 January, 2022

    Baricitinib and sotrovimab for severe or critical disease and non-severe cases respectively...

    COVID-19

  • Supreme Court allows vaccine mandate for federally funded healthcare workers

    United States // 14 January, 2022

    Healthcare workers at federally funded health facilities are required to be vaccinated...

    COVID-19

  • Supreme Court rules against OSHA vaccine mandate

    United States // 14 January, 2022

    The Supreme Court has halted the vaccine mandate requiring businesses with 100 or more employees to be vaccinated...

    COVID-19

  • COVID-19 Update – Tests generally not required for mild symptoms

    Finland // 14 January, 2022

    Health authorities have updated the testing and quarantine guidelines...

    COVID-19

  • First cases of Omicron detected

    Suriname // 13 January, 2022

    Latest testing confirms variant…

    COVID-19

  • Study: Air pollution exposure increases the risk of COVID-19

    13 January, 2022

    Long-term exposure to ambient (outdoor) air pollution increases the risk of COVID-19...

    COVID-19, Air Pollution, General Articles

  1. …
  2. 21
  3. 22
  4. 23
  5. 24
  6. 25
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS